Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Iran in transition.

Danaei G, Farzadfar F, Kelishadi R, Rashidian A, Rouhani OM, Ahmadnia S, Ahmadvand A, Arabi M, Ardalan A, Arhami M, Azizi MH, Bahadori M, Baumgartner J, Beheshtian A, Djalalinia S, Doshmangir L, Haghdoost AA, Haghshenas R, Hosseinpoor AR, Islami F, Kamangar F, Khalili D, Madani K, Masoumi-Asl H, Mazyaki A, Mirchi A, Moradi E, Nayernouri T, Niemeier D, Omidvari AH, Peykari N, Pishgar F, Qorbani M, Rahimi K, Rahimi-Movaghar A, Tehrani FR, Rezaei N, Shahraz S, Takian A, Tootee A, Ezzati M, Jamshidi HR, Larijani B, Majdzadeh R, Malekzadeh R.

Lancet. 2019 May 11;393(10184):1984-2005. doi: 10.1016/S0140-6736(18)33197-0. Epub 2019 Apr 28. Review.

PMID:
31043324
2.

Birth seasonality in rural areas of Iran, analysis of 5,536,262 births from 1992 to 2007.

Khajavi A, Pishgar F, Parsaeian M, Moghaddam SS, Jeddian A, Bahrami-Taghanaki HR, Jamshidi HR, Naderimagham S.

Ann Epidemiol. 2016 Dec;26(12):846-852.e3. doi: 10.1016/j.annepidem.2016.09.009. Epub 2016 Oct 4.

PMID:
28340910
3.

National and Subnational Patterns of Cause of Death in Iran 1990-2015: Applied Methods.

Sheidaei A, Gohari K, Kasaeian A, Rezaei N, Mansouri A, Khosravi A, Parsaeian M, Mohammadi Y, Mehdipour P, Rahimzadeh S, Sharifi F, Varmaghani M, Chegini M, Naderimagham S, Jamshidi HR, Farzadfar F.

Arch Iran Med. 2017 Jan;20(1):2-11. doi: 0172001/AIM.003.

4.

Using drug sales data to evaluate the epidemiology of cardiometabolic risk factors and their inequality: an ecological study on atorvastatin and total cholesterol in Iran.

Ahmadvand A, Farzadfar F, Jamshidi HR, Mohammadi N, Holakouie-Naieni K.

Med J Islam Repub Iran. 2015 Sep 9;29:260. eCollection 2015.

5.

Burden of Cancers in Iran from 1990 to 2010: findings from the Global Burden of Disease study 2010.

Modirian M, Rahimzadeh S, Cheraghi Z, Saeedi Moghaddam S, Rezaei N, Tohidinik HR, Kasaeian A, Jamshidi HR, Ghobadi R, Kompani F.

Arch Iran Med. 2015 Oct;18(10):629-37. doi: 0151810/AIM.004.

6.

Burden of Hepatitis C in Iran Between 1990 and 2010: findings from the Global Burden of Disease Study 2010.

Mohaghegh Shalmani H, Noori A, Shokoohi M, Khajavi A, Darvishi M, Delavari A, Jamshidi HR, Naderimagham S.

Arch Iran Med. 2015 Aug;18(8):508-14. doi: 015188/AIM.008.

7.

Tobacco Smoking Status and the Contribution to Burden of Diseases in Iran, 1990-2010: findings from the Global Burden of Disease Study 2010.

Ghasemian A, Rezaei N, Saeedi Moghaddam S, Mansouri A, Parsaeian M, Delavari A, Jamshidi HR, Sharifi F, Naderimagham S.

Arch Iran Med. 2015 Aug;18(8):493-501. doi: 015188/AIM.006.

8.

Burden of Drug and Alcohol Use Disorders in Iran: findings from the Global Burden of Disease Study 2010.

Moazen B, Shokoohi M, Noori A, Rahimzadeh S, Saeedi Moghaddam S, Rezaei F, Lotfizadeh M, Kazemi MR, Jamshidi HR, Pazhuheian F, Rabbani S, Naderimagham S.

Arch Iran Med. 2015 Aug;18(8):480-5. doi: 015188/AIM.004.

9.

The Most Prevalent Causes of Deaths, DALYs, and Geriatric Syndromes in Iranian Elderly People Between 1990 and 2010: findings from the Global Burden of Disease study 2010.

Namazi Shabestari A, Saeedi Moghaddam S, Sharifi F, Fadayevatan R, Nabavizadeh F, Delavari A, Jamshidi HR, Naderimagham S.

Arch Iran Med. 2015 Aug;18(8):462-79. doi: 015188/AIM.003.

10.

National and sub-national prevalence, trend, and burden of end stage renal diseases (ESRD) in Iran 1990-2013; the study protocol.

Hassannia T, Farzadfar F, Noori A, Moradi-Lakeh M, Delavari F, Jamshidi HR, Djalalinia S, Naderimagham S.

Arch Iran Med. 2014 Dec;17(12):800-3. doi: 0141712/AIM.004.

11.

National and sub-national burden of breast cancer in Iran; 1990-2013.

Naderimagham S, Alipour S, Djalalinia S, Kasaeian A, Noori A, Rahimzadeh S, Modirian M, Khosravi A, Etemad K, Jamshidi HR, Farzadfar F.

Arch Iran Med. 2014 Dec;17(12):794-9. doi: 0141712/AIM.003.

12.

"Budget impact analyses": a practical policy making tool for drug reimbursement decisions.

Jamshidi HR, Foroutan N, Salamzadeh J.

Iran J Pharm Res. 2014 Summer;13(3):1105-9.

13.

Costs of Treatment after Renal Transplantation: Is it Worth to Pay More?

Salamzadeh J, Foroutan N, Jamshidi HR, Rasekh HR, Rajabzadeh Gatari A, Foroutan A, Nafar M.

Iran J Pharm Res. 2014 Winter;13(1):271-8.

14.

Cost-Effectiveness Evaluation of Quadrivalent Human Papilloma Virus Vaccine for HPV-Related Disease in Iran.

Khatibi M, Rasekh HR, Shahverdi Z, Jamshidi HR.

Iran J Pharm Res. 2014 Winter;13(Suppl):225-34.

15.

National and sub-national burden of chronic diseases attributable to lifestyle risk factors in Iran 1990 - 2013; study protocol.

Ghasemian A, Ataie-Jafari A, Khatibzadeh S, Mirarefin M, Jafari L, Nejatinamini S, Parsaeian M, Peykari N, Sobhani S, Jamshidbeygi E, Jamshidi HR, Ebrahimi M, Etemad K, Moradi-Lakeh M, Larijani B, Farzadfar F.

Arch Iran Med. 2014 Mar;17(3):146-58. doi: 0141703/AIM.004.

16.

National and sub-national trend and burden of injuries in Iran, 1990 - 2013: a study protocol.

Jamshidbeygi E, Rastad H, Qorbani M, Saadat S, Sepidarkish M, Asayesh H, Sepanlou SG, Shokraneh F, Najafi F, Khoramdad M, Maghsodi A, Farzadfar F, Jamshidi HR, Moradi-Lakeh M, Farzadfar F.

Arch Iran Med. 2014 Mar;17(3):138-45. doi: 0141703/AIM.003. Review.

17.

National and sub-national prevalence, trend, and burden of metabolic risk factors (MRFs) in Iran: 1990 - 2013, study protocol.

Peykari N, Sepanlou SG, Djalalinia S, Kasaeian A, Parsaeian M, Ahmadvand A, Koohpayehzadeh J, Damari B, Jamshidi HR, Larijani B, Farzadfar F.

Arch Iran Med. 2014 Jan;17(1):54-61. doi: 0141701/AIM.009.

18.

NASBOD 2013: design, definitions, and metrics.

Farzadfar F, Delavari A, Malekzadeh R, Mesdaghinia A, Jamshidi HR, Sayyari A, Larijani B.

Arch Iran Med. 2014 Jan;17(1):7-15. doi: 0141701/AIM.004.

19.

Budget impact analysis of conversion from cyclosporine to sirolimus as immunosuppressive medication in renal transplantation therapy.

Foroutan N, Rasekh HR, Salamzadeh J, Jamshidi HR, Nafar M.

Clinicoecon Outcomes Res. 2013 Oct 18;5:545-53. doi: 10.2147/CEOR.S51446. eCollection 2013.

20.

Prevention by L-arginine/nitric oxide of chlordiazepoxide-induced toxic reactions in the rat salivary gland.

Ahmed AO, Sharifzadeh M, Nikfar S, Jamshidi HR, Abdollahi M.

Toxicol Mech Methods. 2006;16(6):331-7. doi: 10.1080/15376520600620067.

PMID:
20021032
21.

Socioeconomic inequality in infant mortality in Iran and across its provinces.

Hosseinpoor AR, Mohammad K, Majdzadeh R, Naghavi M, Abolhassani F, Sousa A, Speybroeck N, Jamshidi HR, Vega J.

Bull World Health Organ. 2005 Nov;83(11):837-44. Epub 2005 Nov 10. Erratum in: Bull World Health Organ. 2005 Dec;83(12):965.

22.

Some thoughts on medical education in the twenty-first century.

Jamshidi HR, Cook DA.

Med Teach. 2003 May;25(3):229-38. No abstract available.

PMID:
12881042
23.

Pre-marriage prevention of thalassaemia: report of a 100,000 case experience in Isfahan.

Ghanei M, Adibi P, Movahedi M, Khami MA, Ghasemi RL, Azarm T, Zolfaghari B, Jamshidi HR, Sadri R.

Public Health. 1997 May;111(3):153-6.

PMID:
9175458

Supplemental Content

Loading ...
Support Center